Jul 21, 2026, 13:05
Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
Danai Poutakidou, Member (Alternate) of the Accreditation Commission for Medical Specialists in Clinical Biology, Head of Hematology Department at Brussels University Hospital Laboratory LHUB-ULB, shared a post on LinkedIn:
“Delighted to showcase the work of our LHUB‑ULB hemostasis team at ISTH2026.
This case underlines how expert analytical review and proper reagent selection help uncover a Lupus Anticoagulant behind an unexpected PT/INR prolongation, avoiding major diagnostic pitfalls.
Grateful to our hemostasis experts Kleio Ouzounelli and Mirvate Harb for their key contributions to this challenging and insightful investigation.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 21:12Ammar Al Awawdeh: Bridging the Hemostatic Gap – Functional Platelet Salvage in CPB
-
Jul 21, 2026, 19:44Shinya Goto: JCS/JPCPHS 2025 Guideline Now Available in English
-
Jul 21, 2026, 19:43Abdul Mannan: Why Is HbS or HbD Approximately 40% in Heterozygotes Rather Than 50%?
-
Jul 21, 2026, 19:42Haemophilia Maintains a 2025 Impact Factor of 3.0 – WFH
-
Jul 21, 2026, 19:41Wolfgang Miesbach: SR604 Restores Thrombin Generation Where It Is Needed
-
Jul 21, 2026, 19:40Filmon Tesfay: Our New Case Report on Cerebral Venous Thrombosis Is Now Published
-
Jul 21, 2026, 15:02Sham Zamil: The Role of ABO Compatibility in Platelet Pooling
-
Jul 21, 2026, 13:43Dima Shulkin: Assessing AI-Driven Blood Test Screening for Colorectal Cancer
-
Jul 21, 2026, 13:24Benoit Mores: National Initiative Targets Better Cardiovascular Outcomes